Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial-Reference-Cited by-同舟云学术

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial

Published:2017-11 Issue:10108 Volume:390 Page:2143-2159
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Huh Warner K,Joura Elmar A,Giuliano Anna R,Iversen Ole-Erik,de Andrade Rosires Pereira,Ault Kevin A,Bartholomew Deborah,Cestero Ramon M,Fedrizzi Edison N,Hirschberg Angelica L,Mayrand Marie-Hélène,Ruiz-Sternberg Angela Maria,Stapleton Jack T,Wiley Dorothy J,Ferenczy Alex,Kurman Robert,Ronnett Brigitte M,Stoler Mark H,Cuzick Jack,Garland Suzanne M,Kjaer Susanne K,Bautista Oliver M,Haupt Richard,Moeller Erin,Ritter Michael,Roberts Christine C,Shields Christine,Luxembourg Alain

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Global burden of human papillomavirus and related diseases;Forman;Vaccine,2012

2. A review of clinical trials of human papillomavirus prophylactic vaccines;Schiller;Vaccine,2012

3. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study;de Sanjose;Lancet Oncol,2010

4. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases;Garland;N Engl J Med,2007

5. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis;Drolet;Lancet Infect Dis,2015

Cited by 340 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the landscape of HPV-associated cancers: From epidemiology to prevention;Pathology - Research and Practice;2024-11

2. Fibroblast stromal support model for predicting human papillomavirus-associated cancer drug responses;Journal of Virology;2024-09-13

3. Unveiling the seroprevalence of human papillomavirus in Guangdong, China: Implications for vaccination strategies;Journal of Medical Virology;2024-09

4. Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort study;npj Vaccines;2024-08-13

5. HPV Vaccination Information Access, Needs, and Preferences Among Black and Hispanic Mothers;Journal of Health Communication;2024-08-11